首页> 外文期刊>Asian Journal of Pharmaceutical Research and Health Care >Genetic and Non-Genetic Factors Association with Warfarin Long Term Therapy Stability in Sudan
【24h】

Genetic and Non-Genetic Factors Association with Warfarin Long Term Therapy Stability in Sudan

机译:遗传和非遗传因素与苏丹华法林长期治疗的稳定性

获取原文
           

摘要

Anticoagulation with warfarin is characterized by a wide inter-individual variations in dose requirements and INR (International Normalised Ratio) stability, as there are evidences that warfarin response variability is associated with CYP2C9 (cytochrome P450, family 2, subfamily C, polypeptide 9) and VKORC1 (Vitamin K epoxide reductase complex1) genetic polymorphisms. Carriers of CYP2C9*2 and VKORC11639G>A variant alleles are at greater risk of unstable anticoagulation therapy. Objectives: This retrospective case control study was directed to analyze the impact of genetic and non-genetic factors on warfarin therapy in Sudanese out-patients who were on long term warfarin therapy. Method: 118 Sudanese outpatients receiving warfarin treatment for at least six months, were interviewed for their non-genetic factors that included age, sex, indication for warfarin therapy, compliance, Vitamin K rich foods intake and concomitant drug therapy, in addition to their blood samples which were taken for DNA extraction and genotyping of CYP2C9*2 and VKORC11639G>A gene polymorphisms to study the genetic factors. INR stability % index was calculated, accordingly patients were classified into 2 groups, stable and unstable groups. Results: The frequencies of VKORC11639G>A alleles in Sudanese out-patients who were on long term warfarin therapy were 70.3% and 29.7% for the VKORC1/G and VKORC1/A alleles respectively. The frequencies of CYP2C9*2 alleles in Sudanese out-patients were 92.4% and 7.6% for CYP2C9*1 and CYP2C9*2 alleles respectively. Variables associated with low INR stability were VKCOR1/AA genotype (p-value = 0.028) and sex (p = 0.017). Variables that showed no association with INR stability were age (p-value = 0.259), compliance (p-value = 0.058). Vitamin K rich foods intake (p- value = 0.743), and mean stable warfarin dose (p-value = 0.439). Conclusion: Polymorphism in warfarin drug target gene VKORC1-11639G>A and sex are important elements of INR stability in Sudanese out- patients on long term warfarin therapy.
机译:华法林抗凝的特点是剂量需求和INR(国际标准化比率)的稳定性在个体间存在广泛差异,因为有证据表明华法林反应变异性与CYP2C9(细胞色素P450,家族2,亚家族C,多肽9)和VKORC1(维生素K环氧还原酶复合物1)遗传多态性。 CYP2C9 * 2和VKORC11639G> A变异等位基因的携带者不稳定抗凝治疗的风险更高。目的:这项回顾性病例对照研究旨在分析遗传和非遗传因素对长期接受华法林治疗的苏丹门诊患者的华法林治疗的影响。方法:对118名接受华法令治疗至少六个月的苏丹门诊患者进行了非遗传因素的采访,包括年龄,性别,华法令疗法的适应症,依从性,富含维生素K的食物摄入量以及伴随的药物疗法以及血液分别采集CYP2C9 * 2和VKORC11639G> A基因多态性进行DNA提取和基因分型,以研究其遗传因素。计算INR稳定性%指数,将患者分为稳定和不稳定两组。结果:长期接受华法林治疗的苏丹门诊患者中,VKORC1 / G和VKORC1 / A等位基因的VKORC11639G> A等位基因频率分别为70.3%和29.7%。 CYP2C9 * 1和CYP2C9 * 2等位基因在苏丹门诊的CYP2C9 * 2等位基因频率分别为92.4%和7.6%。与低INR稳定性相关的变量是VKCOR1 / AA基因型(p值= 0.028)和性别(p = 0.017)。与INR稳定性无关的变量是年龄(p值= 0.259),依从性(p值= 0.058)。富含维生素K的食物摄入量(p值= 0.743)和平均稳定的华法林剂量(p值= 0.439)。结论:华法林药物靶基因VKORC1-11639G> A和性别的多态性是长期接受华法林治疗的苏丹门诊患者INR稳定的重要因素。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号